Turk Ilac Ve Serum Sanayi Anonim Sirketi reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TRY 219.63 million compared to TRY 206.75 million a year ago. Net income was TRY 26.27 million compared to TRY 8.22 million a year ago. Basic earnings per share from continuing operations was TRY 0.162 compared to TRY 0.051 a year ago.
For the nine months, sales was TRY 663.12 million compared to TRY 510.5 million a year ago. Net income was TRY 58.18 million compared to TRY 64.29 million a year ago. Basic earnings per share from continuing operations was TRY 0.36 compared to TRY 0.397 a year ago.